AIFM3 — Apoptosis-Inducing Factor Mitochondria 3

Overview

AIFM3 (Apoptosis Factor Mitochondria 3) is a mitochondrial protein homologous to AIFM1 and AIFM2, involved in apoptosis and cell death pathways. AIFM3 represents a relatively uncharacterized member of the AIF family that may play distinct roles in neuronal survival and death.

Gene Information

Protein Structure and Function

AIFM3 shares structural features with other AIF family members:

• N-terminal mitochondrial targeting sequence: Directs the protein to mitochondria ^{1Mitochondrial targeting of AIF proteins (2008)2008 · PMID 18419847Open reference}

• FAD-binding domain: Contains flavin adenine dinucleotide (FAD)-binding capacity, suggesting oxidoreductase activity ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}

• NADH-binding domain: Involved in electron transfer reactions

• C-terminal domain: Mediates interactions with other proteins and DNA

Biochemical Properties

AIFM3 functions as:

• Apoptosis Effector: Mediates caspase-independent cell death pathways, though its pro-apoptotic activity appears weaker than AIFM1 ^{3AIF-mediated cell death (2000)2000 · PMID 11033252Open reference}

• Oxidoreductase: Has NADH oxidase activity, potentially involved in mitochondrial electron transport

• Mitochondrial Localization: Primarily localized to mitochondria, with potential for translocation under certain conditions

Expression Patterns

AIFM3 is expressed in various tissues, with notable expression in:

• Heart and skeletal muscle (high mitochondrial content)

• Brain regions including cortex and hippocampus

• Liver and kidney

Role in Neurodegenerative Diseases

Alzheimer’s Disease

AIFM3 is relevant to AD through several mechanisms:

Mitochondrial Dysfunction: AD is characterized by early mitochondrial dysfunction. AIFM3, as a mitochondrial protein involved in cell death, may contribute to the progressive loss of neuronal mitochondria in AD. ^{4Swerdlow, Mitochondria and AD (2013)2013 · PMID 23558347Open reference}

Oxidative Stress: AIFM3’s oxidoreductase activity connects to oxidative stress in AD. The disease involves increased reactive oxygen species (ROS) production and impaired antioxidant defenses. ^{5Querfurth & LaFerla, Molecular mechanisms of AD (2010)2010 · PMID 20150641Open reference}

Apoptosis vs. Necrosis: AIFM3 mediates caspase-independent cell death, which may be relevant to the necrotic-like cell death observed in AD. The balance between apoptotic and necrotic pathways influences disease progression. ^{6Mattson, Cell death in AD (2000)2000 · PMID 10677276Open reference}

Amyloid-Beta Toxicity: Amyloid-beta oligomers induce mitochondrial dysfunction and cell death. AIFM3 may participate in these pathways, though its specific role in Aβ-induced toxicity remains to be characterized. ^{7O'Brien & Wong, Amyloid-beta and mitochondrial dysfunction (2011)2011 · PMID 21406689Open reference}

Parkinson’s Disease

Dopaminergic Neuron Vulnerability: AIFM3 may influence the selective vulnerability of dopaminergic neurons in the substantia nigra. These neurons have high metabolic demands and are particularly sensitive to mitochondrial dysfunction. ^{8Dauer & Przedborski, PD pathogenesis (2003)2003 · PMID 14597658Open reference}

Mitochondrial Complex I Deficiency: PD involves complex I deficiency. AIFM3’s mitochondrial functions could interact with or be affected by complex I impairment. ^{9Schapira, Complex I deficiency in PD (2008)2008 · PMID 18554328Open reference}

Cell Death Pathways: The death of dopaminergic neurons involves both apoptotic and necrotic mechanisms. AIFM3-mediated cell death pathways may contribute to this process. ^{10Vila & Przedborski, Targeting cell death in PD (2003)2003 · PMID 12941585Open reference}

Amyotrophic Lateral SALS)

Motor Neuron Death: AIFM3 is expressed in motor neurons and may contribute to their degeneration in ALS. The caspase-independent cell death pathway mediated by AIFM3 could be relevant to the necrotic component of motor neuron death. ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}0

Mitochondrial Dysfunction: ALS involves widespread mitochondrial dysfunction, including fragmentation, impaired function, and loss of mitochondrial DNA. AIFM3’s role in mitochondrial quality control may be relevant. ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}1

Excitotoxicity: Glutamate excitotoxicity is a key mechanism in ALS. Excitotoxic stress can induce mitochondrial dysfunction and cell death, potentially involving AIFM3 pathways. ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}2

Stroke and Ischemia

Ischemic Cell Death: AIFM3 may play a role in the caspase-independent cell death that occurs following cerebral ischemia. The mitochondrial permeability transition and release of mitochondrial pro-death factors contribute to infarct expansion. ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}3

Oxidative Damage: Ischemia-reperfusion generates oxidative stress. AIFM3’s oxidoreductase activity could be affected by or contribute to oxidative damage in stroke. ^{2FAD-binding in AIF family (2004)2004 · PMID 15509773Open reference}4

Therapeutic Implications

Targeting AIFM3 pathways presents therapeutic opportunities:

• Inhibition of Caspase-Independent Death: Small molecule inhibitors of AIFM3 could protect neurons from caspase-independent cell death

• Mitochondrial Protection: Strategies to maintain mitochondrial integrity may prevent AIFM3 translocation and cell death

• Oxidoreductase Modulation: Modulating AIFM3’s oxidoreductase activity could influence oxidative stress responses

Interacting Proteins

Protein	Interaction Type	Function
AIFM1	Homolog	Apoptosis induction
AIFM2	Homolog	Apoptosis regulation
VDAC	Pore interaction	Mitochondrial outer membrane
Cytochrome c	Comparison	Electron transport chain
Hsp90	Chaperone interaction	Protein folding

Summary

AIFM3 is a mitochondrial apoptosis-inducing factor with roles in caspase-independent cell death and oxidoreductase activity. Its involvement in mitochondrial dysfunction connects it to the pathogenesis of Alzheimer’s disease, Parkinson’s disease, ALS, and stroke. The caspase-independent cell death pathway mediated by AIFM3 represents an alternative cell death route that may be particularly relevant to the necrotic-like neuronal death observed in neurodegenerative conditions. Understanding AIFM3’s role in neurodegeneration may lead to therapeutic strategies targeting mitochondrial cell death pathways.

See Also

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• PubMed

• KEGG Pathways